Hall Laurie J Trustee Has $542,000 Stake in CVS Health Corporation $CVS

Key Points

• Hall Laurie J Trustee sold 3,513 shares of CVS Health, reducing its stake by 30.5% to 8,000 shares, valued at approximately $542,000.
• CVS Health reported a Q2 earnings of $1.81 per share, exceeding estimates and generating revenue of $98.92 billion, an 8.4% increase from the previous year.
• The company announced a quarterly dividend of $0.665, representing a 3.6% yield with a payout ratio of 74.30%.

Hall Laurie J Trustee trimmed its position in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 30.5% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,000 shares of the pharmacy operator's stock after selling 3,513 shares during the quarter. Hall Laurie J Trustee's holdings in CVS Health were worth $542,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also made changes to their positions in CVS. Essex Financial Services Inc. grew its position in CVS Health by 0.8% in the first quarter. Essex Financial Services Inc. now owns 20,705 shares of the pharmacy operator's stock worth $1,403,000 after acquiring an additional 166 shares in the last quarter. Hemington Wealth Management grew its position in CVS Health by 33.7% in the first quarter. Hemington Wealth Management now owns 682 shares of the pharmacy operator's stock worth $46,000 after acquiring an additional 172 shares in the last quarter. McIlrath & Eck LLC grew its position in CVS Health by 32.6% in the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after acquiring an additional 174 shares in the last quarter. Sumitomo Life Insurance Co. grew its position in CVS Health by 1.0% in the first quarter. Sumitomo Life Insurance Co. now owns 17,114 shares of the pharmacy operator's stock worth $1,159,000 after acquiring an additional 174 shares in the last quarter. Finally, Koshinski Asset Management Inc. grew its position in CVS Health by 3.7% in the first quarter. Koshinski Asset Management Inc. now owns 4,930 shares of the pharmacy operator's stock worth $334,000 after acquiring an additional 178 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Performance

Shares of CVS stock traded up $0.07 during trading hours on Friday, reaching $73.76. 5,074,859 shares of the company's stock were exchanged, compared to its average volume of 5,804,935. The stock has a market capitalization of $93.56 billion, a P/E ratio of 20.60, a P/E/G ratio of 0.81 and a beta of 0.62. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $74.53. The business has a fifty day moving average price of $66.60 and a 200-day moving average price of $65.99. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, beating the consensus estimate of $1.46 by $0.35. The firm had revenue of $98.92 billion during the quarter, compared to analysts' expectations of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The business's quarterly revenue was up 8.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, August 1st. Investors of record on Tuesday, July 22nd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.6%. The ex-dividend date was Tuesday, July 22nd. CVS Health's dividend payout ratio is presently 74.30%.

Analysts Set New Price Targets

Several analysts have commented on the stock. Cantor Fitzgerald reissued an "overweight" rating and issued a $78.00 target price on shares of CVS Health in a research report on Tuesday, August 26th. UBS Group upgraded CVS Health from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $67.00 to $79.00 in a report on Monday, August 18th. Barclays boosted their target price on CVS Health from $80.00 to $87.00 and gave the stock an "overweight" rating in a report on Thursday. Baird R W upgraded CVS Health from a "hold" rating to a "strong-buy" rating in a report on Thursday, August 14th. Finally, Cowen restated a "buy" rating on shares of CVS Health in a report on Monday, August 4th. Two analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus price target of $77.89.

Insider Buying and Selling

In related news, Director Anne A. Finucane sold 7,500 shares of the company's stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the transaction, the director directly owned 22,156 shares in the company, valued at $1,573,519.12. This represents a 25.29% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.22% of the stock is currently owned by insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.